- Home
- DNLI vs TRN Comparison
DNLI vs TRN Comparison
Compare DNLI & TRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | TRN |
|---|---|---|
| Founded | 2013 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DNLI | TRN |
|---|---|---|
| Price | $18.58 | $34.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | ★ $34.33 | $34.00 |
| AVG Volume (30 Days) | ★ 1.3M | 549.0K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | N/A | ★ 85.98 |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $2,156,900,000.00 |
| Revenue This Year | N/A | $1.91 |
| Revenue Next Year | $408.85 | $15.61 |
| P/E Ratio | ★ N/A | $120.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.58 | $22.38 |
| 52 Week High | $23.77 | $36.62 |
Technical Indicators
Market Signals| Indicator | DNLI | TRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 58.71 |
| Support Level | $18.42 | $27.09 |
| Resistance Level | $18.70 | $35.33 |
| Average True Range (ATR) | 0.92 | 1.31 |
| MACD | -0.17 | 0.24 |
| Stochastic Oscillator | 15.41 | 69.06 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About TRN Trinity Industries Inc.
Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.